Research library · 24 briefs
We restored the structure of the old Phthalate Wiki—finding, summary, context, actions, source—then added newer studies and made every limitation impossible to miss.
Product suggestions follow the evidence. They do not replace it, and they are never proof of a health outcome.
Fertility, gestation, placental biology, birth outcomes, and maternal health.
The study examined whether pregnancy exposure markers for phthalates and newer substitutes tracked with blood-pressure patterns and hypertensive disorders.
Higher prenatal phthalate biomarkers were associated with shorter gestation and preterm birth, then modeled as a substantial population burden.
Researchers reported associations between selected urinary phthalate metabolites and thyroid-hormone measures during pregnancy.
Several preconception phthalate metabolites were associated with longer time to pregnancy and with hormonal, inflammatory, or oxidative-stress markers.
Some grouped phthalate biomarkers were associated with higher odds of postpartum-depression symptoms, while most measured chemicals were not.
A prenatal phthalate mixture altered sex-hormone patterns around birth in a mouse study, with different findings in female and male offspring.
Gestational DINP exposure disrupted uterine and placental development in a mouse model.
Higher biomarkers for several common phthalates were associated with increased odds of preterm birth across a large pooled sample.
Higher pregnancy urinary biomarkers for several phthalates were associated with preterm birth, particularly spontaneous preterm birth.
Brain, behavior, motor development, and early-life vulnerability.
Results varied by metabolite and developmental domain, while mixture analyses were not significantly associated with delay in most domains.
Prenatal DEHP exposure was associated with higher autism- and ADHD-related symptom scores at ages two and four, and cord-blood DNA methylation patterns statistically mediated part of those associations.
Most overall associations were null, with a limited number of sex-specific associations that need replication.
A higher prenatal chemical mixture was associated with modestly lower scores on two adolescent cognitive subtests; several phthalate metabolites contributed most to one estimate.
The analysis considered chemical exposure alongside life stress rather than treating environmental risks in isolation.
Selected prenatal phthalate biomarkers were associated with smaller gray or white matter volumes and with lower IQ later in childhood.
Higher prenatal DEHP biomarkers were associated with selected emotional and behavioral measures among two-year-old boys in this cohort.
Prenatal and childhood biomarkers for selected phthalates were associated with lower motor scores, with patterns differing by sex and exposure window.
Interventions that test whether practical or policy changes actually lower biomarkers.
Food with minimal plastic contact reduced several urinary plastic-associated chemical markers within seven days.
Most interventions lowered at least one biomarker, and policy-level changes generally produced the largest reductions.
Three days using personal-care products labeled free of selected chemicals reduced several urinary biomarkers, including monoethyl phthalate.
How exposure is measured and how evidence is translated into protection.
Migration varied sharply among ten molds; dibutyl phthalate exceeded its referenced specific migration limit in the dry-food simulant, while aqueous-simulant results stayed below the criteria used.
Exposure to alternative plasticizers such as DEHTP is increasingly documented, but human health evidence remains limited and does not support treating every substitute as proven safer.
Project TENDR authors concluded that the evidence supported class-based action to reduce ortho-phthalate exposure during brain development.
The archived manual documents the laboratory method used to quantify short-lived phthalate metabolites in urine for NHANES.
Read this before the headlines
Most human phthalate studies are observational. They can reveal consistent patterns, but they cannot prove that a measured metabolite caused an outcome. We weigh larger pooled cohorts, repeated measurements, interventions, and agreement across different kinds of evidence more heavily.